Medicare Advantage Premiums Projected to Drop Significantly by 2027
The Centers for Medicare & Medicaid Services (CMS) has projected that weighted average Medicare Advantage (MA) premiums will decline more than 16% in 2027 compared to current levels. Additionally, the agency estimates a nearly 38% drop in average prescription drug premiums within MA plans during the same period. The anticipated reductions are attributed to increased competition among insurers and improved efficiency in healthcare delivery models under Medicare Advantage programs. These changes could result in significant cost savings for beneficiaries while also influencing insurer strategies across the sector. From a market perspective, these projections may affect investor sentiment toward health insurance providers as well as broader discussions around long-term sustainability of MA plans.
